Vision
- Our aspiration is to lead as a bioprocess innovation company, setting enduring technology standards for decades to come.
- We aim to excel in comprehending and fulfilling the product and service requirements of biopharma, and stem cell therapy centers worldwide.
- Our mission is to supply OmniBRx bioreactors and tools to every bioprocessing lab, fostering exceptional partnerships and mutual success.
Mission
- OmniBRx is a top biotech company offering versatile bioprocessing solutions tailored for exceptionally efficient and scalable cell culture-based bio-manufacturing.
- Our commitment is to drive innovation and furnish solutions for the advancement of stem cell therapies, facilitating efficient and scalable stem cell culture using single-use bioreactors.
- We are committed to developing scalable, efficient, and cost-effective single-use bioreactors for biologics manufacture.
Overview
OmniBRx aims to be the biggest biotech company and positions itself as the leading producer of single-use bioreactors for the biopharmaceutical sector, providing outstanding value to each of our clients through our products and unwavering dedication to service.
We are committed to improving quality, scalability, and predictability in biologics manufacturing, including the manufacture of Vaccines, monoclonal antibodies (M’Abs), and therapeutic mammalian proteins.
As a biotech pharmaceutical company exclusively focused on upstream bioprocessing solutions, we have introduced the cutting-edge CellBRx® range of bioreactors for adherent cell culture bioprocessing. We are prepared to partner with global biopharmaceutical companies, serving as a trusted ally in developing and producing game-changing bioprocess control system solutions. Our portfolio includes automated single-use perfusion bioreactor systems and customized GMP production services, spanning from pre-clinical to commercial scales, catering to quantities ranging from milligrams to kilograms.
Our solutions deliver value to customers by
- Providing scalable culture systems, enhancing mixing and efficiency, spanning from laboratory to production scale for cell culture applications.
- Mitigating production risks through the use of single-use, closed systems.
- Accelerating time-to-market by significantly reducing upstream validation prerequisites.
- Enhancing cell health and quality through advanced biotech, leading to consistent protein expression.
- Minimizing expenses, including capital investments, labor, facilities, and materials, while maximizing protein yield per square foot of production area.
OmniBRx Biotechnologies manufactures state-of-the-art bioreactors recognized for their user-friendliness and technological sophistication within the pharmaceutical biotechnology sector. Our single-use bioreactors offer unmatched per-liter volume efficiency and seamless scalability across all phases of the cell culture process, ranging from R&D to clinical trials and cGMP production. We are dedicated to delivering cost-effective disposable systems alongside exceptional technical services, empowering our clients to overcome intricate cell culture challenges.